01—Abstract
Summary
Summary of the 10-K filed February 11, 2025. Cited figures are marked; the original filing is the authoritative source.
Leidos Holdings, Inc. ("Leidos"), a holding company whose principal operating subsidiary is Leidos, Inc., reported fiscal 2024 (ended January 3, 2025) revenues of $16.66 billiona, up 8% from $15.44 billion in fiscal 2023.
Operating income rose to $1.83 billionb, compared with $621 million in fiscal 2023, which had included $689 million of impairment and restructuring charges at the Security Enterprise Solutions (SES) reporting unit. Operating margin was 11.0% versus 4.0% a year earlier. Net income attributable to Leidos common stockholders was $1.25 billion ($9.22 diluted EPS), compared with $199 million in fiscal 2023.
Approximately 87% of revenues came from U.S. government contracts, and about 8% came from entities outside the United States. Net bookings were $23.4 billionc in fiscal 2024, versus $16.5 billion in fiscal 2023, and total backlog stood at $43.6 billion, including $8.4 billion of funded backlog. Operating cash flow was $1.39 billion.
Cash and cash equivalents were $943 milliond at year-end, and total debt was $4.7 billion. The company paid $850 million in open-market share repurchases during fiscal 2024 and $208 million in dividends, with dividends declared at $1.54 per share. The filing describes a realignment into four reportable segments (National Security & Digital, Health & Civil, Commercial & International, and Defense Systems).
Health & Civil revenue grew 18% to $5.02 billion with operating margin of 21.8%. The filing also flags risks including dependence on U.S. government budgets and appropriations, the continuing resolution that runs through March 14, 2025, competitive bid protests, and fixed-price contract cost overruns.
Goodwill was 46% of total assets. The company disclosed a Department of Justice Antitrust Division grand jury subpoena and an SEC inquiry related to past international operations, and the Department of Justice closed its separate inquiry in December 2024.
02—Key points
Key Highlights
- Revenue of $16.66 billion in fiscal 2024, up 8% from $15.44 billion in fiscal 2023.
- Operating income of $1.83 billion (11.0% operating margin), versus $621 million (4.0% margin) in fiscal 2023, which included $689 million of SES impairment and restructuring charges.
- Net income attributable to Leidos common stockholders of $1.25 billion, or $9.22 diluted EPS, compared with $199 million in fiscal 2023.
- Net bookings of $23.4 billion and total backlog of $43.6 billion, including $8.4 billion of funded backlog as of January 3, 2025.
- Approximately 87% of fiscal 2024 revenues came from U.S. government contracts; National Security & Digital and Health & Civil together represented 44% and 30% of total revenues.
- Operating cash flow of $1.39 billion; $850 million of open-market share repurchases and $208 million of dividends paid in fiscal 2024.
- The U.S. government continuing resolution funds operations through March 14, 2025, and the filing warns that failure to pass appropriations would cause a partial or complete federal government shutdown.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2025, Leidos Holdings kept $0.08.
- Revenue$16.58B100.0%
- Cost of revenue−$13.86B83.6%
- Gross profit$2.71B16.4%
- Operating costs−$885.0M5.3%
- Operating income$1.83B11.0%
- Interest, other & tax−$573.0M3.5%
- Net income$1.25B7.6%
04—Financials
Financial Highlights
Figures from 10-KFY2025filed February 11, 2025Financial Statements
| Revenue | $16.58B |
| Cost of Revenue | $13.86B |
| Gross Profit | $2.71B |
| R&D Expenses | $150.00M |
| SG&A Expenses | $983.00M |
| Operating Income | $1.83B |
| Net Income | $1.25B |
| EPS (Basic) | $9.36 |
| EPS (Diluted) | $9.22 |
| Shares Outstanding (Basic) | 134.00M |
| Shares Outstanding (Diluted) | 136.00M |
05—Questions
Frequently Asked Questions
How did Leidos perform in fiscal 2024 compared with fiscal 2023?
Revenues rose 8% to $16.66 billion, and operating income increased to $1.83 billion from $621 million. The prior-year result included $689 million of impairment and restructuring charges at the SES reporting unit. Net income attributable to Leidos common stockholders was $1.25 billion, compared with $199 million in fiscal 2023.
How dependent is Leidos on the U.S. government?
Approximately 87% of fiscal 2024 revenues came from U.S. government contracts, either as a prime contractor or a subcontractor. Revenues from contracts with the DoD and U.S. Intelligence Community represented about 48% of total revenues. The filing states that budget delays, spending caps, and contract termination for convenience could adversely affect revenues.
What is the company's backlog and bookings position?
Net bookings were $23.4 billion in fiscal 2024, up from $16.5 billion in fiscal 2023. Total backlog was $43.6 billion as of January 3, 2025, of which $8.4 billion was funded and $35.1 billion was unfunded. The company expects to recognize a substantial portion of funded backlog as revenue within the next 12 months.
What legal and regulatory matters does the filing disclose?
The filing discloses that the Department of Justice closed its inquiry into conduct at an international operations business in December 2024, while the SEC investigation remains open with no predicted outcome. It also discloses a federal grand jury subpoena from the DOJ Antitrust Division, issued in August 2022, related to three U.S. government procurements, and states that it is not possible at this time to determine potential fines or liabilities.
What is the company's capital return and balance sheet position?
Leidos had $943 million of cash and cash equivalents and $4.7 billion of total debt at January 3, 2025, and an undrawn $1.0 billion revolving credit facility. In fiscal 2024 it paid $850 million in open-market share repurchases and $208 million in dividends, with dividends declared at $1.54 per share. The company stated it was in compliance with all debt covenants.
06—Continue